Transmembrane protein complexes shed light on antibiotic resistance in bacteria

An international team including researchers from MIPT’s Laboratory for Advanced Studies of Membrane Proteins have proposed an explanation of the way bacteria process external signals. By identifying the detailed structure of the protein complex used by bacteria, the scientists gained insights into the ability of these microorganisms to detect even small changes in the environment and adapt to them. The research findings were published in Scientific Reports.

Alina Remeeva, left, was a researcher at the Institute of Complex Systems 6: Structural Biochemistry, Research Center Jülich, at the time of the study; Valentin Borshchevskiy, senior research scientist at the Laboratory for Advanced Studies of Membrane Proteins; and Piotr Utrobin, an engineer at the Research Center for Molecular Mechanisms of Aging and Aging-Related Diseases. Image courtesy of Evgeniy Pelevin, the press office of MIPT.

Bacteria are extremely good at adapting to the changing environment. This renders many antibiotics ineffective, as the bacterial cell can adapt by developing resistance. Because resistant bacteria can survive the influence of drugs, infectious diseases may be difficult to treat.

To gather information about the outside world, bacteria rely on two-component signal systems constituted by transmembrane protein complexes, i.e., structures made up of two proteins in the cell membrane, one of them “sticking out” and the other protruding on the inside. To understand the mechanism behind the operation of such complexes, we need to determine their precise structure. Knowing how this system works, scientists could then figure out a way to switch it off. This makes membrane protein complexes potentially useful targets for emerging antibiotics.

In their study, the researchers examined the crystal structures of the ground and active state of one of such systems consisting of the sensory photoreceptor rhodopsin II coupled with its cognate transducer. The team has demonstrated that this complex can have a U-shaped structure in addition to the regular V-shaped conformation reported in prior research. The study also explains why this is the case by positing biological relevance of the U-shape in terms of signal transduction.

The team suggested that by transitioning from the U- to the V-shape, the receptor–transducer complex enters its active state, which could be involved in signal transmission between the photoreceptor and the transducer. This is in line with existing biological data. Therefore, it is possible to disrupt signal transduction by treating the cell with a suitable drug preventing the V-to-U transition.

“Our findings have a practical application in dealing with bacterial resistance. Nevertheless, this study is primarily significant for our fundamental understanding of signal transduction mechanisms in bacteria, because they could be involved in thousands of other similar bacterial receptors that are responsible for all kinds of cell functions. These insights will enable us to come up with receptor models that are more precise,” says Valentin Borshchevskiy, a senior research scientist at the Laboratory for Advanced Studies of Membrane Proteins.

Among other bacterial receptors, the protein complex investigated in the study plays a major role in the aspartate (Tar) and serine (Tsr) receptors. The former guides bacteria towards nutrients (e.g., aspartate and maltose) and away from harmful agents (e.g., nickel and cobalt). The latter is used by bacteria like Salmonella and E. Coli to seek serine, which they consume as a nutrient, and avoid harmful acids.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
HNL Dimer as a promising biomarker for monitoring antibiotic treatment in sepsis